The role of peripheral inflammation-related biomarkers in distinguishing Parkinson's disease

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

Stephen N. Gomperts, Joseph J. Locascio, Dorene M. Rentz et al. · Neurology · 2012 · 181 citations · Full text

Medicine, Neurology, Neuroscience +17

Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease

Veselin Grozdanov, Luc Bousset, Corinna Bliederhaeuser et al. · Annals of Neurology · 2019 · 162 citations · Full text

Life Sciences, Immunology, Neuroscience +17

NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy

Rachael H. Earls, Kelly B. Menees, Jaegwon Chung et al. · Proceedings of the National Academy of Sciences · 2020 · 147 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson’s disease

Zhu Liu, Qingli Fan, Shizheng Wu et al. · Lipids in Health and Disease · 2021 · 109 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Alterations in Blood Monocyte Functions in Parkinson's Disease

Sara Konstantin Nissen, Kalpana Shrivastava, Claudia Schulte et al. · Movement Disorders · 2019 · 93 citations

Life Sciences, Immunology, Neurology +17